The potential of theragnostic 124I-8H9 convection-enhanced delivery in diffuse intrinsic pontine glioma Academic Article uri icon

Overview

MeSH Major

  • Antibodies, Monoclonal
  • Brain Stem Neoplasms
  • Glioma
  • Radioimmunotherapy

abstract

  • The safety and feasibility of (124)I dosimetry following CED via PET is demonstrated, establishing a preclinical framework for a trial evaluating CED of (124)I-8H9 for diffuse intrinsic pontine glioma.

publication date

  • January 2014

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC4022223

Digital Object Identifier (DOI)

  • 10.1093/neuonc/not298

PubMed ID

  • 24526309

Additional Document Info

start page

  • 800

end page

  • 6

volume

  • 16

number

  • 6